Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 250 results in range #51 to #300.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Annual intake
  2. Annual limit on intake
  3. Apoptosis
  4. Application of ionising radiation in healthcare
  5. Application of ionising radiation in healthcare (old)
  6. Area monitoring
  7. Attributable risk
  8. Auger transition
  9. Authorised discharge
  10. Authorization
  11. Authorized limit
  12. Autoimmune disease
  13. Automatic exposure control
  14. Autonomy
  15. Averted dose
  16. Background dose (rate)
  17. Backscatter detection system
  18. Backscatter factor
  19. Basal cell
  20. Baseline disease rates
  21. Beneficence
  22. Benthic
  23. Best available techniques
  24. Beta-minus decay
  25. Beta-plus decay
  26. Bioassay
  27. Biological half-life
  28. Biomarker
  29. Biomedical research volunteer
  30. Bioturbation
  31. Bone marrow
  32. Brachytherapy
  33. Bradycardia
  34. Bragg peak
  35. Branching fraction
  36. Breakpoint cluster region/abelson
  37. Broad beam therapy irradiation technique
  38. Bronchial region
  39. Bronchiolar region
  40. Bystander effect
  41. Calculating Doses from Intakes of Radionuclides
  42. Calculating Radon Doses
  43. Cardiac arrhythmias
  44. Cardiac valve diseases
  45. Cardiomyopathy
  46. Cardioverter-defibrillator
  47. Carers and comforters
  48. Case–control study
  49. Cell death
  50. Charged-particle equilibrium
  51. Chronic exposure
  52. Class SR-0 gases
  53. Class SR-1 gases
  54. Class SR-2 gases
  55. Clearance
  56. Clearance level
  57. Clinical audit
  58. Clonogenic cells
  59. Clonogenic survival
  60. Clonogenic surviving fraction
  61. Co-expertise
  62. Cobblestone area forming cell assay
  63. Cohort study
  64. Collective dose
  65. Collective effective dose
  66. Collimation
  67. Colony
  68. Commissioning
  69. Committed effective dose
  70. Committed equivalent dose
  71. Compartment
  72. Compartment (environmental)
  73. Complex tissues
  74. Computed tomography dose index
  75. Concentration ratio
  76. Cone beam computed tomography
  77. Connective tissue
  78. Consequential late effects
  79. Constancy test
  80. Containment
  81. Contamination
  82. Coronary heart disease
  83. Cosmic Radiation in Aviation
  84. Cosmic radiation
  85. Cost-benefit analysis
  86. Coster-Kronig transition
  87. Count median diameter
  88. Cross section
  89. Cumulative dose
  90. Curie
  91. Cytokines
  92. DNA damage signalling
  93. DRL process
  94. DRL quantity
  95. DRL value
  96. DS02
  97. DS86
  98. Decay constant
  99. Decommissioning
  100. Decontamination
  101. Decontamination factor
  102. Dental and maxillofacial imaging
  103. Deontological Ethics
  104. Deposition
  105. Derived air concentration
  106. Derived consideration reference level
  107. Derived investigation level
  108. Derived limit
  109. Derived reference level
  110. Designated area
  111. Detector quantum efficiency
  112. Deterministic effect
  113. Detriment
  114. Detriment-adjusted risk
  115. Diagnostic reference level
  116. Diastasis
  117. Dicentric chromosome
  118. Dichotomous
  119. Differentiation
  120. Digital breast tomosynthesis
  121. Dignity
  122. Directional dose equivalent
  123. Disposal
  124. Disposal facility
  125. Distribution coefficient
  126. Dose
  127. Dose-length product
  128. Dose-rate effect
  129. Dose-response function
  130. Dose-threshold
  131. Dose-threshold hypothesis
  132. Dose and dose-rate effectiveness factor
  133. Dose coefficient
  134. Dose commitment
  135. Dose constraint
  136. Dose conversion coefficient
  137. Dose conversion convention
  138. Dose conversion factor
  139. Dose criteria
  140. Dose equivalent
  141. Dose limit
  142. Dose limits
  143. Dose modifying factor
  144. Dose of record (E)
  145. Dose of record Hp (10)
  146. Dose per content function
  147. Dose per unit intake coefficient
  148. Dose rate
  149. Dose rate effectiveness factor
  150. Doubling dose
  151. Early normal tissue responses
  152. Edema
  153. Effect Dose 50
  154. Effect modifier
  155. Effective charge number
  156. Effective dose
  157. Effective dose equivalent
  158. Effective half-life
  159. Effects of Exposure
  160. Electron-capture decay
  161. Electrophysiology
  162. Elemental dose
  163. Emergency
  164. Emergency exposure situation
  165. Emergency plan
  166. Emergency preparedness
  167. Emergency procedures
  168. Employer
  169. Endogeneous excretion
  170. Endosteum
  171. Environmental exposure
  172. Environmental radiation protection
  173. Epigenetic effects
  174. Epithelium
  175. Equieffective dose
  176. Equilibrium equivalent concentration
  177. Equilibrium factor
  178. Equity
  179. Equivalent dose
  180. Erythropoietin
  181. Ethics
  182. Evacuation
  183. Excess absolute risk
  184. Excess relative risk
  185. Exclusion
  186. Excretion rate (instantaneous)
  187. Exempt waste
  188. Exemption level
  189. Existing exposure situation
  190. Exogenous excretion
  191. Expanded and aligned radiation field
  192. Expanded radiation field
  193. Exponential survival curve
  194. Exposed individuals
  195. Exposure, external or internal
  196. Exposure (in the context of inhalation)
  197. Exposure Categories and Situations
  198. Exposure index
  199. Exposure pathway
  200. Exposure situation
  201. Exposure to Radon at Home
  202. Extrathoracic airways
  203. Fairness
  204. Field-size effect (Volume effect)
  205. Flexible tissues
  206. Fluence
  207. Fluoroscopically guided interventions
  208. Fluoroscopically or computed tomography guided interventions
  209. Forbiddenness
  210. Fractional absorption in the gastrointestinal tract
  211. Fractionation
  212. Fractionation and dose delivery patterns
  213. Fractionation sensitivity
  214. Frequent flyer
  215. Functional subunits
  216. Fundamental Principles of Radiological Protection
  217. GATA binding protein 2
  218. Galactic cosmic radiation
  219. Gamma ray
  220. Gastrointestinal syndrome
  221. Gastroschisis
  222. Gastrulation
  223. General Information on Radon
  224. Genomic integrity
  225. Graded approach
  226. Graft vs host disease
  227. Granulocyte-macrophage colony-stimulating factor
  228. Granulocyte colony-stimulating factor
  229. Gray
  230. Ground-level enhancement
  231. Growth factor
  232. Growth fraction
  233. Growth hormone (somatotropin)
  234. Guide to Radiological Protection in Healthcare
  235. Guide to Radon
  236. Guide to the System of Radiological Protection
  237. Habitual mouth breather
  238. Habitual nose breather
  239. Half-life, physical
  240. Hazard
  241. Health Surveillance
  242. Heliosphere
  243. Hereditary effect
  244. Hierarchical tissues
  245. High level waste
  246. High linear energy transfer radiation
  247. Homologous recombination
  248. Hormones
  249. Hounsfield unit
  250. Human Alimentary Tract Model

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:WithoutInterwiki"